deacetoxyvinzolidine has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acs, T; Keve, T; Kovács, J; Löw, P; Orosz, F; Ovádi, J; Urbányi, Z; Vértessy, BG | 1 |
| Acs, T; Cascante, M; Comin, B; Keve, T; Kovács, J; Orosz, F; Ovádi, J; Puigjaner, J; Raïs, B; Tárkányi, G | 1 |
2 other study(ies) available for deacetoxyvinzolidine and Leukemia P388
| Article | Year |
|---|---|
Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calmodulin; Cattle; CHO Cells; Cricetinae; Drug Screening Assays, Antitumor; Immunohistochemistry; Insecta; Leukemia P388; Mice; Microscopy, Electron; Protein Binding; Rats; Tubulin; Tumor Cells, Cultured; Vinblastine; Vincristine | 1997 |
New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calmodulin; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Microtubules; Neuroblastoma; Structure-Activity Relationship; Vinblastine | 1999 |